SEARCH

SEARCH BY CITATION

References

  • 1
    Berson SA, Yalow RS, Aurbach GD, Potts JT 1963 Immunoassay of bovine and human parathyroid hormone. Proc Natl Acad Sci USA 49:613617.
  • 2
    Woodhead JS, Davies SJ, Lister D 1977 Two-site assay of bovine parathyroid hormone. J Endocrinol 73:279288.
  • 3
    Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV 1987 Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 33:13641367.
  • 4
    Potts JT, Segre GV, Endres DB 1983 Current clinical concept: Assessment of parathyroid function with an N-terminal specific radioimmunoassay for intact parathyroid hormone. Nicholes Institute, Los Angeles, CA, USA, pp. 19.
  • 5
    Gao P, Schmidt-Gayk H, Dittrich K, Nolting B, Maier A, Roth HJ, Seemann O, Reichel H, Ritz E, Schilling T 1996 Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone. Clin Chim Acta 245:3959.
  • 6
    Martin KJ, Hruska KA, Freitag JJ, Klahr S, Slatopolsky E 1979 The peripheral metabolism of parathyroid hormone. N Engl J Med 302:10921098.
  • 7
    Quarles LD, Lobough B, Murphy G 1992 Intact parathyroid hormone over-estimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145150.
  • 8
    Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ 1993 Aplastic osteodystrophy without aluminium: The role of “suppressed” parathyroid function. Kidney Int 44:860866.
  • 9
    Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG 1994 Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253258.
  • 10
    Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C, D'Amour P 1998 A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805809.
  • 11
    Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M, D'Amour P 1996 Accumulation of a non-(1–84) molecular form of parathyroid (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:39233929.
  • 12
    Jueppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM 1991 A G protein-linked receptor for the parathyroid hormone and parathyroid hormone-related peptide. Science 254:10241026.
  • 13
    Usdin TB, Gruber C, Bonner TI 1995 Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270:1545515458.
  • 14
    Bringhurst FR, Stern AM, Yotts M, Mizrahi N, Segre GV, Potts JT Jr 1988 Peripheral metabolism of PTH: Fate of biologically active amino terminus in vivo. Am J Physiol 255:E886E893.
  • 15
    Fox J, Scott M, Nissenson RA, Heath H 1983 Effects of plasma calcium concentration on the metabolic clearance rates of parathyroid hormone in the dog. J Lab Clin Med 102:7077.
  • 16
    Brasier AR, Wang CA, Nussbaum SR 1988 Recovery of parathyroid hormone secretion after parathyroid adenomectomy. J Clin Endocrinol Metab 66:495500.
  • 17
    Mazzuoli G, Minisola S, Scarnecchia L, Pacitti MT, Carnevale V, Romagnoli E, Bigi F, Bianchi G 1990 Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: Study in basal condition, following adenoma removal and during calcium and EDTA infusion. Clin Chim Acta 190:239248.
  • 18
    Gao P, Eberle AE 1997 One-step two-site immunoluminometric assay of parathyroid hormone-related protein. In: Schmidt-GaykH, BlindE, RothHJ (eds.) Calcium Regulating Hormones and Markers of Bone Metabolism: Measurement and Interpretation, 2nd Ed. Verlag Klinisches Labor GmbH Heidelberg, Germany, pp. 7983.
  • 19
    Bennett HPJ, Solomon S, Goltzman D 1981 Isolation and analysis of human parathyrin in parathyroid tissue and plasma. Biochem J 197:391400.
  • 20
    Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, D'Amour P 2000 Influence of glomerular filtration rate on non-(1–84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697703.
  • 21
    John MR, Goodman WG, Gao P, Cantor T, Salusky IB, Jueppiner H 1999 A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:42874290.
  • 22
    Gao P, Fulla Y, Scheibel S, Vuillemard C, Cantor T 2000 Recognition of the PTH(7–84) fragment by 5 commercial PTH “sandwich” assays. J Bone Miner Res 15:S1;S564.
  • 23
    Kao PC, van Heerden JA, Grant CS, Klee GC, Khosa S 1992 Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 67:637645.
  • 24
    Endres DB, Villanueva R, Sharp CF Jr, Singer FR 1991 Immunochemiluminometric immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 37:162168.
  • 25
    Silverberg S, Brown IN, Bilezikian JP, Deftos LJ 2000 A new highly sensitive assay for parathyroid hormone in primary hyperparathyroidism. J Bone Miner Res 15:S1;S167.
  • 26
    Slatopolsky E, Finch JL, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A 2000 A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753761.
  • 27
    Inomata N, Akiyama M, Kubota N, Jueppner H 1995 Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH(1–84). Endocrinology 136:47324740.